Autophagy in Cardiovascular Aging

DOI Web Site 1 Citations
  • Mahmoud Abdellatif
    From the Department of Cardiology, Medical University of Graz, Austria (M.A., S.S.)
  • Simon Sedej
    From the Department of Cardiology, Medical University of Graz, Austria (M.A., S.S.)
  • Didac Carmona-Gutierrez
    BioTechMed Graz, Austria (S.S., D.C.-G., F.M.)
  • Frank Madeo
    BioTechMed Graz, Austria (S.S., D.C.-G., F.M.)
  • Guido Kroemer
    Equipe 11 Labellisée Ligue Contre le Cancer, Centre de Recherche des Cordeliers, Paris, France (G.K.)

Description

<jats:p>Cardiovascular diseases are the most prominent maladies in aging societies. Indeed, aging promotes the structural and functional declines of both the heart and the blood circulation system. In this review, we revise the contribution of known longevity pathways to cardiovascular health and delineate the possibilities to interfere with them. In particular, we evaluate autophagy, the intracellular catabolic recycling system associated with life- and health-span extension. We present genetic models, pharmacological interventions, and dietary strategies that block, reduce, or enhance autophagy upon age-related cardiovascular deterioration. Caloric restriction or caloric restriction mimetics like metformin, spermidine, and rapamycin (all of which trigger autophagy) are among the most promising cardioprotective interventions during aging. We conclude that autophagy is a fundamental process to ensure cardiac and vascular health during aging and outline its putative therapeutic importance.</jats:p>

Journal

  • Circulation Research

    Circulation Research 123 (7), 803-824, 2018-09-14

    Ovid Technologies (Wolters Kluwer Health)

Citations (1)*help

See more

Details 詳細情報について

Report a problem

Back to top